All In MedTech

Device Trial Radar · NCT07775469

Comparison Study for Hemodynamic Parameters Generated by Vitalstream Relative to Appropriate Gold Standard References in Different Clinical Settings, (OR, EP Lab Etc.).

Vitalstream Gold Standard Study

Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 24, 2026

Primary completion

Aug 24, 2027

Study completion Feb 1, 2028

Sponsor

Lead sponsor
CareTaker Medical LLCNot on our public-company list
Sponsor type
Industry
First posted
Aug 20, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of the proposed study is to test the capability of the Vitalstream monitor's continuous blood pressure tracking ability against Gold Standard.

Conditions

  • No Specific Conditions Are Being Examined

Interventions

  • VitalstreamDevice

    Non-invasive BP monitoring. No intervention

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. BP Reading AgreementTime frame: 30 minutes to 24 hours

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.